Sanofi SA

05/15/2022 | Press release | Distributed by Public on 05/15/2022 03:28

Press Release: Sarclisa® (isatuximab) combination provides unprecedented median progression free survival in patients with relapsed multiple myeloma receiving a proteasome[...]